- Home
- ALLO vs SI Comparison
ALLO vs SI Comparison
Compare ALLO & SI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | SI |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 376.2M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ALLO | SI |
|---|---|---|
| Price | $1.22 | $19.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $9.00 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 5.2M | 97.5K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.09 | ★ 98.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $47,317,000.00 |
| Revenue This Year | N/A | $44.61 |
| Revenue Next Year | $255.46 | $29.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.63 |
| 52 Week Low | $1.04 | $10.92 |
| 52 Week High | $4.46 | $24.60 |
Technical Indicators
Market Signals| Indicator | ALLO | SI |
|---|---|---|
| Relative Strength Index (RSI) | 24.71 | 60.00 |
| Support Level | N/A | $19.33 |
| Resistance Level | $2.22 | $20.03 |
| Average True Range (ATR) | 0.08 | 0.92 |
| MACD | -0.00 | 0.20 |
| Stochastic Oscillator | 0.00 | 72.96 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About SI Shoulder Innovations Inc.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.